Aqua Medical Advances PIMA Trial for Type 2 Diabetes
PLEASANTON, Calif., August 18, 2026 Aqua Medical, Inc. announced the treatment of the first West Coast patient in its...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
PLEASANTON, Calif., August 18, 2026 Aqua Medical, Inc. announced the treatment of the first West Coast patient in its...
AKRON, Ohio, August 18, 2026 Resivant Medical announced the successful completion of the first patient cases using its Cutivaâ„¢...
BURLINGTON, Massachusetts, USA, April 28, 2026 SQ Innovation has announced that its drug-device combination therapy Lasix® ONYU has achieved...
